Pacific Biosciences of California, Inc. Q4 Loss Increases, but beats estimates

(RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for its fourth quarter that increased from the same period last year and missed the Street estimates.

The company's earnings came in at -$84.38 million, or -$0.37 per share. This compares with -$69.33 million, or -$0.31 per share, in last year's fourth quarter.

Excluding items, Pacific Biosciences of California, Inc. reported adjusted earnings of -$79.56 million or -$0.35 per share for the period.

Analysts on average had expected the company to earn -$0.36 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 8.9% to $27.35 million from $30.02 million last year.

Pacific Biosciences of California, Inc. earnings at a glance (GAAP) :

-Earnings (Q4): -$84.38 Mln. vs. -$69.33 Mln. last year. -EPS (Q4): -$0.37 vs. -$0.31 last year. -Analyst Estimate: -$0.36 -Revenue (Q4): $27.35 Mln vs. $30.02 Mln last year.